Overview

Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis

Status:
Unknown status
Trial end date:
2010-09-01
Target enrollment:
0
Participant gender:
All
Summary
To assess the effects of lactulose for the prevention of first episode of altered sensorium (hepatic encephalopathy, primary prophylaxis) in patients with cirrhosis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Govind Ballabh Pant Hospital
Treatments:
Lactulose
Criteria
Inclusion Criteria:

- cirrhotic patients(18-70yrs) who never had encephalopathy

Exclusion Criteria:

- history of taking lactulose in the past 6 weeks

- alcohol intake during the past 6 weeks

- hepatocellular carcinoma

- previous TIPS or shunt surgery

- significant co morbid illness such as heart, respiratory, or renal failure

- neurologic diseases such as alzheimer's disease, parkinson's disease and nonhepatic
metabolic encephalopathies.

- patients on psychoactive drugs such as antidepressants or sedatives

- who restarted alcohol during follow up